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ABSTRACT: Cell surface glycosylation serves a fundamental role
in dictating cell and tissue behavior. Cell surface glycomes diﬀer
signiﬁcantly, presenting viable biomarkers for identifying cell types
and their states. Glycoproﬁling is a challenging task, however, due to
the complexity of the constituent glycans. We report here a rapid
and eﬀective sensor for surface-based cell diﬀerentiation that uses a
three-channel sensor produced by noncovalent conjugation of a
functionalized gold nanoparticle (AuNP) and ﬂuorescent proteins.
Wild-type and glycomutant mammalian cells were eﬀectively
stratiﬁed using ﬂuorescence signatures obtained from a single
sensor element. Blinded unknowns generated from the tested cell
types were identiﬁed with high accuracy (44 out of 48 samples),
validating the robustness of the multichannel sensor. Notably, this
selectivity-based high-throughput sensor diﬀerentiated between cells, employing a nondestructive protocol that required only a
single well of a microplate for detection.
■ INTRODUCTION
Cell-surface glycans present an intricate and complex interface
that plays a central role in numerous processes such as cell−cell
recognition, pathogenesis, inﬂammation, cancer, and immune
surveillance of tumors.1,2 The composition of cell-surface
glycans signiﬁcantly varies with diﬀerent cell states, such as
stem-cell diﬀerentiation, tissue development, and cancer.3,4 For
example, sialyl Lewis X and sialyl Lewis A tetrasaccharides are
overexpressed in certain cancers that are strongly metastatic.5,6
These distinct cell-surface glycan “signatures” associated with
each cell state provide key biomarkers for identifying healthy
and malignant cell states with applications in both fundamental
glycobiology and diagnostics.7,8
Proﬁling cell states based on glycosylation patterns is
challenging due to the complex structures of the glycans,
such as the presence of linkage isomers and branching events.9
A number of strategies10 including lectin arrays,11 antiglycan
antibodies,12,13 and synthetic receptors14−16 have been used to
construct cell-surface saccharide biosensors. Application of
these speciﬁcity-based sensors in identifying cell states is often
limited owing to the diﬃculty in synthesis, poor stability of the
constituents, high cost, and immunogenicity. Signature-based
methods provide a potentially complementary alternative to
speciﬁc biomarker identiﬁcation: mass spectrometry of the cell-
surface glycome has been employed successfully to diﬀerentiate
between normal and cancerous cell states.10,17,18 However, the
added processing steps such as carbohydrate extraction,
sophisticated analysis, and expensive instrumentation required
by these methods restrict their use in rapid assays and introduce
artifacts arising from the processing steps.
Direct readout of glycosylation signatures from the cell
surfaces, particularly on living cells, would provide access to key
glycomic information. Unbiased signature-based “chemical
nose/tongue” methods that employ diﬀerential binding of
analytes with sensor arrays provide a powerful alternative to
biomarker-based approaches.19 In this approach, a unique
“ﬁngerprint” is derived for each analyte interacting with the
sensor, and subsequent comparison of the detected proﬁle of a
target analyte allows its classiﬁcation and identiﬁcation. Owing
to the inherent generalizability of this strategy, signature-based
sensing method presents a powerful tool for discriminating
between diﬀerent classes of analytes and their complex
mixtures.20,21 This sensing strategy has eﬀectively been applied
to detecting bioanalytes including proteins,22−25 bacteria,26,27
and mammalian cells,28−31 even in biological matrices.32,33
Despite the eﬃcacy of array-based sensors in diagnostics,
current systems are capable of producing only single channel
measurements of the molecular recognition, requiring multiple
spatially distinct sensor elements for identifying one analyte and
limiting their application in rapid high-throughput screening of
bioanalytes.34
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In recent studies, we developed a supramolecular three-
channel sensor system that uses diﬀerent ﬂuorescent proteins
to generate a multiplex output.35 Notably, the sensing approach
utilizing simultaneous three-channel output requires only one
sensor to correctly identify multiple cell types leading to
detection from a single well of a microplate. We report here an
important application of this strategy in diﬀerentiating
mammalian cells based on their surface glycan signatures. We
have fabricated a new three-channel sensor using gold
nanoparticles featuring a glycan recognizing functional
ligand36−38 to successfully identify both glycomutant (mostly
charged glycans) and glycosidase-modiﬁed wild-type cells. This
identiﬁcation was performed on living cells using the
microplates they were grown on, demonstrating a non-
destructive cell sensing method. Here, the directness of the
measurement precludes additional processing steps such as
extracting the glycans/proteoglycans or labeling the cells prior
to analyses. The ability of this biosensor to detect cells based on
overall glycan proﬁles, as opposed to the commonly used
sensors focused on monosaccharides,14 circumvents the
limitations arising from the complexity of glycan structures
and makes the sensor applicable to a vast number of cell types.
Finally, this work provides fundamental insight into the
molecular mechanism of previous studies on sensing
mammalian cells that used selectivity-based array sensors,28−31
revealing the direct connection between the cell-surface
glycome and phenotypic diﬀerences of various cell types and
states.
■ RESULTS AND DISCUSSION
We fabricated the three-channel sensor by noncovalent
complexation of three ﬂuorescent proteins (FPs) and
arginine-ligand protected AuNP (ArgNP) (Figure 1A; see
Figures S1−S7 for the synthesis and characterization of
ArgNP). In this sensor, the FPs provide multivalent binding
with the particles, as well as stable measurement of molecular
recognition events between the particle and cell surfaces. We
screened diﬀerent ﬂuorescent proteins and utilized an
optimized set for fabricating the sensor: EBFP2 (blue), EGFP
(green), and tdTomato (red). We selected this set of proteins
based on the following criteria:39 (a) the proteins bear net
negative charges [calculated pKa values of 6.4 (EBFP2), 6.0
(EGFP), and 6.5 (tdTomato) including His6-tag] and show
diﬀerent binding aﬃnities with the particle; (b) the FPs feature
well-separated excitation and emission wavelengths with
minimal spectral cross-talk, allowing us to obtain independent
responses from each emission channel; (c) monomeric or
tandem-dimeric structure of the FPs streamlines their use in
displacement assays relative to other multimeric analogues; and
(d) the photostability of the FPs provides reliable ﬂuorescence
outputs. For the recognition element, ArgNP with exposed
arginine headgroup (Figure 1A) was used in the sensor based
on the selective interaction of arginine with various glycans. For
example, the arginine moiety is involved in high-aﬃnity binding
with the sulfonate groups of sulfated glycans (e.g., glyco-
saminoglycans)36,37 as well as with carboxylate groups of
hyaluronan and sialic acid through salt-bridge interactions,
regulating the function of protein−glycan interface.38
Initially, we investigated the binding parameters of the
ArgNP−FP complexes, since the binding thermodynamics of
the particle and the FPs plays a central role in the sensor
mechanism. Titration of a 1:1:1 mixture of the three FPs with
ArgNP resulted in pronounced quenching of the FP
ﬂuorescence at NP surface saturation (Figure 1B), indicating
that the FPs were quantitatively bound to the NP surface.
Nonlinear least-squares curve ﬁtting analysis of the ﬂuorescence
titration provided the dissociation constant (Kd) for each FP
complex (Table S1), revealing high aﬃnity of each FP for the
particle. Despite the similarity in protein structures, the binding
proﬁles of each protein varied signiﬁcantly, suggesting that
diﬀerential ﬂuorescence responses would be generated for each
FP upon interaction of the sensor with competing analytes such
as mammalian cells.
The FP ﬂuorescence is eﬃciently quenched by the particle
core in the ArgNP−FP supramolecular complexes. When these
complexes are incubated with cells, competitive binding of the
particle to the cell results in rapid (seconds/minutes)
displacement of FPs from the particle surface with consequent
regeneration of FP ﬂuorescence (Figure 2). The characteristic
ﬂuorescence signature enables us to discern between
mammalian cells with diﬀerent glycosylation patterns.
The utility of the sensor platform in rapid sensing of
mammalian cells based on cell-surface glycosylation pattern was
demonstrated ﬁrst using glycomutant cells featuring diﬀerent
glycosaminoglycans (GAGs) as part of the cell surface
proteoglycans. These isogenic cells (that possess the same
genetic background) with diﬀering cell surface glycomes
provide a reliable testbed for discerning cell states based on
characteristic glycosylation patterns.40 We selected a set of
GAG-mutated Chinese hamster ovary (CHO) cell types
(CHO-K1, pgsB-618, pgsA-745, and pgsD-677)41,42 as initial
sensing targets. The role of cell surface glycan expression in
cellular malignancies has been well established for the CHO cell
Figure 1. Assembly of the three-channel sensor. (A) Schematic
illustration of the sensor fabrication by incubating the FPs and ArgNP.
Structure of the ligand on the NP monolayer is shown at the bottom.
(B) Fluorescence titration of an equimolar mixture of the three FPs by
ArgNP in 5 mM sodium phosphate buﬀer (pH 7.4). The data points
are obtained by averaging three replicates, and the error bars represent
±SD. The solid lines through the data represent the best nonlinear
curve ﬁtting.
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types,41,43 e.g., GAG-engineered CHO cell types that produce
heparan sulfate (HS) proteoglycan <10% of the wild-type cells
are tumorigenically transformed.41 Diﬀerent features of the
CHO cell types related to our study and their states are
presented in Table 1.
The ﬁrst step of sensing was to “train” the sensor and build a
statistical model for discerning the glycomic signatures of the
respective cell lines. We determined that 10,000 cells provided
reproducible ﬂuorescence response based on single-well
detection. Upon incubation of the sensor with the wild-type
and GAG mutant cells cultured on a 96-well microplate, a
characteristic ﬂuorescence response pattern was generated
corresponding to each cell type within minutes (Figure 3A).
The ﬁngerprint response patterns indicate diﬀerential inter-
actions of the ArgNP−FP supramolecular complexes with the
cell surfaces. The responses were compared across the cell
types using an unsupervised agglomerative hierarchical
clustering analysis (HCA) that classiﬁed the cells into separate
branches of a cluster dendrogram (Figure 3B). Furthermore,
the ﬂuorescence responses were quantitatively analyzed using
linear discriminant analysis (LDA), a statistical method that
transforms multivariate data into a reduced number of variables
through orthogonal linear combinations (see Supporting
Information and ref 33 for details on the statistical method).
LDA on the sensor outputs categorized them into four non-
overlapping clusters (Figure 3C) corresponding to each cell
type, showing the ability of the sensor to rapidly distinguish
between the GAG mutant cells.
To test the quality of the LDA classiﬁer, leave-one-out cross-
validation analysis was performed on all the response data.
Jackknife analysis (see Supporting Information methods) on
the training data set (4 cell lines × 8 replicates) revealed 100%
between-group cross-validation accuracy (Figure 3D), indicat-
ing the LDA method to be a robust statistical tool for this
system (see Table S2 for all the cells involved in this work).
The Wilks lambda, a statistical parameter that represents the
ratio between residual variance over the total variance, for the
training set was derived to be 0.004 (F = 62.2, P = 0.0000), the
small value of which supports LDA to be a strong model45 for
the present analyses.
Based on the ﬂuorescence responses, the GAG mutant cells
caused signiﬁcantly less FP displacement from the particle
surface than the wild-type CHO cells. This result is anticipated,
as the lesser amount of negatively charged GAGs on these
mutant cell surfaces should result in lesser FP displacement
based on electrostatic interactions. Interestingly, pgsD-677 cells
lacking HS, the most sulfated glycan, produced higher
regenerated ﬂuorescence compared to the other two GAG
mutant cells containing low level of cell-surface HS.
Presumably, the higher ﬂuorescence response from the HS-
deﬁcient pgsD-677 cells originates from the preferential
interactions of ArgNP with chondroitin sulfate (CS) along
with other glycans present on the cell surface. In fact, the GAG
pool of wild-type CHO cell surfaces has been shown to consist
of about 70% HS and 30% CS.41 The variation in ﬂuorescence
responses as a function of small changes on cell surface GAGs
demonstrates the ability of the sensor to detect subtle change in
glycosylation.
There is the possibility of dissimilar downstream processes of
the mutated cell lines: in addition to glycans the cell surfaces
may diﬀer in other surface biomolecules such as proteins and
lipids that could interact with the cationic particle. We
compared sensor responses from the GAG-mutated cell lines
with that of glycosidic enzyme-treated wild-type cells
(diminished glycans) to demonstrate the glycan basis of our
sensor system. In these studies, wild-type CHO-K1 cells were
Figure 2. Schematic illustration of the principle of cell sensing using the multichannel approach. The heatplot is obtained by hierarchical clustering of
the experimental data (average of 8 replicates) for all the glycomutated cells studied. The color codes of the heatplot represent the z-score of the
ﬂuorescence responses along each FP channel, where I and I0 are the ﬂuorescence with and without cells, respectively. B: EBFP2. R: tdTomato. G:
EGFP.
Table 1. Characteristics of the CHO Cell Lines41,43,44 Studied Using the Sensor Platform
cell line biochemical defect glycan composition cell status
CHO-K1 none wild-type tumorigenic
pgsB-618 galactosyltransferase I deﬁcient proteoglycan deﬁcient (15% of wild-type cells) tumorigenic
pgsA-745 xylosyltransferase deﬁcient proteoglycan deﬁcient (8% of wild-type cells) nontumorigenic
pgsD-677 lacks N-acetylglucosaminyltransferase and glucuronyltransferase
activities
HS deﬁcient; produces 3−4-fold higher CS than CHO-K1 cellsa nontumorigenic
Lec-1 N-acetyl-D-glucosamine (GlcNAc) transferase I deﬁcient does not synthesize complex- or hybrid-type N-linked
oligosaccharides
tumorigenic
Lec-2 unable to translocate CMP-sialic acid to Golgi apparatus N- and O-linked sialic acid deﬁcient tumorigenic
aHS: heparan sulfate. CS: chondroitin sulfate.
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treated with the glycosidic enzymes (Table 2) at a
concentration that resulted in maximum GAG cleavage. We
monitored the cleavage by an increase in absorbance at 232 nm,
owing to an unsaturated double bond introduced during the
cleavage between hexosamines and uronic acids.47 Upon
incubation of the sensor with the enzyme-treated cells, good
similarity in ﬂuorescence response was observed between the
enzyme-treated and glycomutant cell lines (Figure 4A). We
performed unsupervised HCA to visualize the relation between
the enzyme-treated and the glycomutated cells. As shown in
Figure 4B, the pgsD-677 cells and heparinase-treated cells were
clustered together, indicating the similarity of HS-cleaved and
HS-deﬁcient cells. Likewise, pgsB-618 and pgsA-745 cells were
grouped with chondroitinase and (chondroitinase + heparin-
ase)-treated cells, with close proximity to crude Flavobacterium
heparinum enzyme-treated cells. While the absolute values were
somewhat diﬀerent, the general trend of the enzyme-treated
cells was quite similar to that of the GAG-mutated cells. Taken
together, we can conﬁdently conclude that NP−GAG
interactions are the major contributor in generating the sensor
responses.
An important outcome from the enzymatic GAG-degrada-
tion study is the contribution of CS to the ﬂuorescence
responses. The higher ﬂuorescence response from HS-deﬁcient
pgsD-677 cell line indicates a temporal structure of GAGs in
the glycocalyx of the wild-type CHO cells, where CS can be
exposed after heparinase I treatment. In fact, the sensor
response is considerably diminished following chondroitinase
treatment, reﬂecting a higher aﬃnity of the particles to CS.
Therefore, the molecular recognition of ArgNP and diﬀerent
glycans is quite selective, making the sensor applicable to
diverse cell types and states.
Our sensor system could reliably diﬀerentiate between cells
featuring changes in negatively charged GAG-modiﬁed cells.
Figure 3. Fluorescence ﬁngerprints of GAG-engineered cells. (A) Fluorescence responses of the cells upon incubation with the sensor for 30 min,
where I0 and I are respectively the ﬂuorescence before and after the addition of the sensor to the cells. The data are obtained by averaging eight
independent replicates, and the error bars represent the ±SD. (B) The dendrogram derived from unsupervised hierarchical clustering analysis of the
ﬂuorescence responses that are averages of 8 replicates. HCA was performed using the average linkage method, where the distance metric is
Euclidean distance. (C) LDA score plot of the ﬂuorescence responses. The analysis resulted in canonical scores with three discriminants explaining
96.1 and 3.9% of total variance and was plotted with 95% conﬁdence ellipses around the centroid of each group. (D) Cross-validation of LDA on the
data set. Jackknife analysis using leave-one-out exercise was performed on all the replicate data.
Table 2. Glycosidic Enzymes Used To Cleave Cell Surface Glycans from CHO Cells, Their Functions, and the Expected
Similarity to the GAG-Engineered Cell Lines
enzyme function expected similarity with
heparinase I and III cleaves heparin and heparan sulfate at the 1−4 linkages between hexosamines and O-sulfated
iduronic acids, yielding mainly disaccharides
HS-deﬁcient cell type (e.g., pgsD-677)









contains chondroitinase, dermatanase, heparinase, and heparitinase activity46 and thus
degrades all the sulfated GAGs
GAG-deﬁcient cell type (e.g., pgsB-618
and pgsA-745)
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Distinguishing cells with more subtle variations in their cell
surface glycome poses a challenging task. To assess the broader
applicability of the sensor to other glycosylation changes, we
used two mutated CHO cell lines as a testbed (Table 1): (i)
Lec-1 cells,44 with N-acetyl-D-glucosamine transferase I
deﬁciency lacking complex and hybrid type N-glycans, resulting
in increase of high-mannose type N-glycans instead; (ii) Lec-2
cells,48 with a mutation in the gene encoding a sialyltransfer-
asethe transporter of CMP-sialic acid from the cytosol to
Golgi vesicleresulting in dramatically reduced sialic acid in
their glycocalyx. The ﬂuorescence responses from Lec-1 and
Lec-2 cells were quantitatively diﬀerent from each other as well
as from the parental CHO-K1 cells (Figure 5A). LDA of the
ﬂuorescence responses clustered the three cells into three
distinct groups (Figure 5B), demonstrating their eﬀective
classiﬁcation. While noncharged glycan-engineered cells were
eﬃciently distinguished, the sensor was further tested on cell
types with distinct phenotypes, featuring wild-type glycomic
signatures. Isogenic murine mammary cell lines possessing
normal, cancerous, and metastatic phenotypes (CDβGeo, pTD,
and V14, respectively) generated characteristic ﬂuorescence
responses that grouped the cells into three distinct clusters
(Figure S8), validating the versatility of the sensor.
After demonstrating the ability of our system to diﬀerentiate
between both glycomutants and glycosidase-modiﬁed cells, we
assessed the contribution from each FP in generating the
diﬀerential ﬂuorescence responses. Analysis of the ﬂuorescence
responses from the six cell lines revealed that each of the FP
channels signiﬁcantly impacts the overall sensing capabilities
(see discussion in the Supporting Information, and Figures S9,
S10, and S11). In addition, correlation (Pearson’s) of the
canonical scores along each discriminant with the ﬂuorescence
response from the FPs showed the contribution from each FP
(Figure S10), reﬂecting the involvement of all the FPs in the
ﬂuorescence displacement process.
The goal of our study was to identify cells based on their
surface glycome. The clustering studies described above are the
ﬁrst step in generating the sensor system, in eﬀect training the
system to identify glycomic signatures. Identiﬁcation of
unknowns demonstrates both the robustness of our clustering
strategy and the potential utility of this method for diagnostic
applications. We utilized the six CHO cell lines as the training
set and performed tests on a randomized set of 48 unknown
samples prepared from these cells that were blinded to the
researcher running the test and the analyses. Identiﬁcation was
Figure 4. Comparison between ﬂuorescence signatures of glycoengineered and glycosidic enzyme-treated CHO cells. (A) Fluorescence responses
along the three FP channels upon interaction with the wild-type and glycosidic enzyme-treated CHO cells, where I0 and I are respectively the
ﬂuorescence before and after the addition of the sensor to the cells. The data are obtained by averaging ﬁve replicates and the error bars represent the
±SD. (B) The cluster dendrogram obtained from HCA on the average ﬂuorescence responses. HCA was performed using the average linkage
method, where the distance metric is Euclidean distance. Chon: chondroitinase ABC. Hep I: heparinase I. Hep III: heparinase III. Crude: crude
enzyme mixture isolated from F. heparinum cells.
Figure 5. Diﬀerentiation of CHO cell types with N-linked
carbohydrate and sialic acid deﬁciency. (A) Fluorescence responses
along the three FP channels upon interaction with the parental and the
Lec cells, where I0 and I are respectively the ﬂuorescence before and
after the addition of the sensor to the cells. The data are obtained by
averaging eight replicates, and the error bars represent the ±SD. (B)
LDA of the ﬂuorescence responses resulted in canonical scores with
two discriminants explaining 99.0 and 1.0% of total variance and were
plotted with 95% conﬁdence ellipses around the centroid of each
group.
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done using the Mahalanobis distance-square49 (deﬁned as the
distance between a point and a distribution) proximities of the
unknowns to the centroid of each group, established from the
training set (see Supporting Information methods). The test
was able to identify 44 samples correctly (92%, Table S6),
demonstrating the reproducibility of the responses and
reliability of the sensor in detecting cells. Notably, the eﬃcacy
of our approach to identify isogenic mammalian cells bearing
diﬀerent negatively charged glycan composition (GAG,
hyaluronic acid, sialylated glycans) indicates the diﬀerential
speciﬁcities of sensor toward the cell-surface glycans. Given the
eﬃciency of the electrostatic interaction-based sensors in
identifying diﬀerent cell types/states,28−31,35,50,51 the present
three-channel sensor should enable screening of a far larger
variety of cells, complementing existing glycan-based cell
detection strategies.
■ CONCLUSIONS
In summary, we have developed a rapid and eﬃcient
multichannel sensor that employs supramolecular interactions
of ﬂuorescent proteins and a functionalized gold NP. This
system responds to diﬀerent glycan patterns, both charged and
noncharged, on cell surfaces. Healthy and cancerous cells with
the same genetic background and exhibiting diﬀerent cell
surface glycome signatures were eﬀectively discerned within a
single well of a microplate without extracting proteoglycans or
labeling speciﬁc sugar units. Signiﬁcantly, the present study
demonstrated the role of glycans in identifying cell states using
nonspeciﬁc sensors, an important step forward to designing
eﬀective signature-based biodiagnostics. Taken together, the
ability to recognize cells combined with the high-throughput
features of the sensor holds great promise in personalized
screening of disease states, and cell-based proﬁling of the
mechanisms of carbohydrate therapeutics.52 In addition, the
selectivity of the nanoparticle−glycan interactions opens up
new opportunities for developing inhibitors for physiological
protein−glycan binding,53 point-of-care assays for glycan
biomarkers in bioﬂuids,54 and targeted imaging agents.1,15
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